Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Precision Therapeutics Inc. (AIPT)

1.17 -0.01 (-0.85%)

08-20 16:00

Open:

1.2

Pre. Close:

1.18

High:

1.2592

Low:

1.16

Volume:

87,659

Market Cap:

16M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.268 - 1.28

1.28 - 1.288

Low:

1.135 - 1.151

1.151 - 1.16

Close:

1.153 - 1.177

1.177 - 1.192

Technical analysis  (as of: 2018-08-20 4:36:00 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 1.43     One year: 1.54

Support:

Support1: 1.08    Support2: 0.90

Resistance:

Resistance1: 1.23    Resistance2: 1.32

Pivot:

1.21

Moving Averages:

MA(5): 1.21     MA(20): 1.19

MA(100): 1.09     MA(250): 1.21

MACD:

MACD(12,26): 0.01     Signal(12,26,9): 0.01

%K %D:

%K(14,3): 31.63     %D(3): 48.46

RSI:

RSI(14): 46.86

52-Week:

High: 2.5  Low: 0.81  Change(%): -19.9

Average Vol(K):

3-Month: 26137  10-Days 10366

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
AIPT has closed above bottom band by 21.6%. Bollinger Bands are 48.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to AIPT's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-08-14T22:47:11-04:00
Precision Therapeutics Inc. (AIPT) CEO Carl Schwartz on Q2 2018 Results - Earnings Call Transcript

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Medical Instruments Supplies

Shares Out. (M)

13.40

Shares Float (M)

10.36

% Held by Insiders

25.80

% Held by Institutions

1.90

Shares Short (K)

796

Shares Short Prior Month (K)

Stock Financials

EPS

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

3.130

PEG Ratio

Profit Margin

Operating Margin

-903.19

Return on Assets (ttm)

-142.4

Return on Equity (ttm)

-177.6

Qtrly Rev. Growth

135.0

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-5.00

Levered Free Cash Flow (M)

-1.34

Valuation

P/E

P/E Growth Ratio

P/BV

0.37

P/S

115049992.00

P/CF

-3.14

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2016-10-28

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.